Review
doi: 10.2217/17435889.2.2.143.
Regulatory issues surrounding nanomedicines: setting the scene for the next generation of nanopharmaceuticals
- PMID: 17716116
- DOI: 10.2217/17435889.2.2.143
Item in Clipboard
Review
Regulatory issues surrounding nanomedicines: setting the scene for the next generation of nanopharmaceuticals
Nanomedicine (Lond).
2007 Apr.
No abstract available
Similar articles
-
Strategies for developing and commercializing nanobio drugs, diagnostics and devices.Nanomedicine (Lond). 2007 Apr;2(2):137-41. doi: 10.2217/17435889.2.2.137. Nanomedicine (Lond). 2007. PMID: 17716115 No abstract available.
-
Regulating Medicines in a Globalized World With Increased Recognition and Reliance Among Regulators: A National Academies Report.JAMA. 2020 Jul 14;324(2):145-146. doi: 10.1001/jama.2019.21793. JAMA. 2020. PMID: 32134427 No abstract available.
-
Safe drugs and the cost of good intentions.N Engl J Med. 2009 Apr 2;360(14):1378-80. doi: 10.1056/NEJMp0900092. N Engl J Med. 2009. PMID: 19339718 No abstract available.
-
Updated Regulatory Considerations for Nanomedicines.Pharm Nanotechnol. 2017;5(3):180-191. doi: 10.2174/2211738505666170615095542. Pharm Nanotechnol. 2017. PMID: 28641516 Review.
-
Nanomedicines: From Bench to Bedside and Beyond.AAPS J. 2016 Nov;18(6):1373-1378. doi: 10.1208/s12248-016-9961-7. Epub 2016 Aug 1. AAPS J. 2016. PMID: 27480318 Review.
Cited by
-
Do nanomedicines require novel safety assessments to ensure their safety for long-term human use?Drug Saf. 2009;32(8):625-36. doi: 10.2165/00002018-200932080-00002. Drug Saf. 2009. PMID: 19591528 Review.
-
Differences in Physico-Chemical Properties and Immunological Response in Nanosimilar Complex Drugs: The Case of Liposomal Doxorubicin.Int J Mol Sci. 2023 Sep 2;24(17):13612. doi: 10.3390/ijms241713612. Int J Mol Sci. 2023. PMID: 37686418 Free PMC article.
-
The Emerging Role of Ultrasonic Nanotechnology for Diagnosing and Treatment of Diseases.Front Med (Lausanne). 2022 Feb 22;9:814986. doi: 10.3389/fmed.2022.814986. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35273976 Free PMC article. Review.
-
Gold Nanoparticles as a Potent Radiosensitizer: A Transdisciplinary Approach from Physics to Patient.Cancers (Basel). 2020 Jul 23;12(8):2021. doi: 10.3390/cancers12082021. Cancers (Basel). 2020. PMID: 32718058 Free PMC article. Review.
-
Recent Progress in Lipid Nanoparticles for Cancer Theranostics: Opportunity and Challenges.Pharmaceutics. 2021 Jun 7;13(6):840. doi: 10.3390/pharmaceutics13060840. Pharmaceutics. 2021. PMID: 34200251 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
